Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccines Against Malaria
Amed Ouattara, Matthew B. Laurens
Clinical Infectious Diseases (2014) Vol. 60, Iss. 6, pp. 930-936
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Peptide-Based Vaccines: Current Progress and Future Challenges
Ryan J. Malonis, Jonathan R. Lai, Olivia Vergnolle
Chemical Reviews (2019) Vol. 120, Iss. 6, pp. 3210-3229
Open Access | Times Cited: 493
Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health
Chelsea N. Fries, Elizabeth J. Curvino, Jui‐Lin Chen, et al.
Nature Nanotechnology (2020) Vol. 16, Iss. 4, pp. 1-14
Open Access | Times Cited: 194
Plants as sources of natural and recombinant anti-cancer agents
Johannes F. Buyel
Biotechnology Advances (2018) Vol. 36, Iss. 2, pp. 506-520
Closed Access | Times Cited: 188
3D-QSAR, docking and ADMET properties of aurone analogues as antimalarial agents
Hanine Hadni, Menana Elhallaoui
Heliyon (2020) Vol. 6, Iss. 4, pp. e03580-e03580
Open Access | Times Cited: 74
Peptides for Vaccine Development
Ian W. Hamley
ACS Applied Bio Materials (2022) Vol. 5, Iss. 3, pp. 905-944
Open Access | Times Cited: 65
2D and 3D-QSAR, molecular docking and ADMET propertiesin silicostudies of azaaurones as antimalarial agents
Hanine Hadni, Menana Elhallaoui
New Journal of Chemistry (2020) Vol. 44, Iss. 16, pp. 6553-6565
Closed Access | Times Cited: 69
Prevention of re-establishment of malaria: historical perspective and future prospects
S Nasir, Dulshara Sachini Amarasekara, Renu Wickremasinghe, et al.
Malaria Journal (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 61
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria
Sodiomon B. Sirima, Alphonse Ouédraogo, Alfred B. Tiono, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 674
Open Access | Times Cited: 30
Seasonal variations in Plasmodium falciparum genetic diversity and multiplicity of infection in asymptomatic children living in southern Ghana
Joshua Adjah, Bless Fiadzoe, Ruth Ayanful‐Torgby, et al.
BMC Infectious Diseases (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 53
Novel, fully human, anti-PfCSP antibodies with potent antimalarial activity using a phage display based strategy
Sadaf Parveen, Pragyan Parimita Rath, Shams Tabrez, et al.
Vaccine (2025) Vol. 54, pp. 126993-126993
Open Access
Immune Correlate-Guided HIV Vaccine Design
Galit Alter, Dan H. Barouch
Cell Host & Microbe (2018) Vol. 24, Iss. 1, pp. 25-33
Open Access | Times Cited: 40
Optimized Blanching Reduces the Host Cell Protein Content and Substantially Enhances the Recovery and Stability of Two Plant-Derived Malaria Vaccine Candidates
Stephan Menzel, Tanja Holland, Alexander Boes, et al.
Frontiers in Plant Science (2016) Vol. 7
Open Access | Times Cited: 39
Comparison of ELISA with electro-chemiluminescence technology for the qualitative and quantitative assessment of serological responses to vaccination
Jessica S. Bolton, Sidhartha Chaudhury, Sheetij Dutta, et al.
Malaria Journal (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 38
The Delay in the Licensing of Protozoal Vaccines: A Comparative History
M Palatnik, Dirlei Nico
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 33
3D-QSAR, molecular docking, DFT and ADMET studies on quinazoline derivatives to explore novel DHFR inhibitors
Hanine Hadni, Mohamed Bakhouch, Menana Elhallaoui
Journal of Biomolecular Structure and Dynamics (2021) Vol. 41, Iss. 1, pp. 161-175
Closed Access | Times Cited: 30
PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial
Drissa Coulibaly, Abdoulaye K. Koné, Karim Traoré, et al.
EClinicalMedicine (2022) Vol. 52, pp. 101579-101579
Open Access | Times Cited: 19
Development of multi-epitope driven subunit vaccine in secretory and membrane protein of Plasmodium falciparum to convey protection against malaria infection
Rajan Kumar Pandey, Mudassar Ali, Rupal Ojha, et al.
Vaccine (2018) Vol. 36, Iss. 30, pp. 4555-4565
Closed Access | Times Cited: 36
Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
Tarsila Mendes de Camargo, Elisângela Oliveira de Freitas, Alba Marina Gimenez, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 33
Variations in killer-cell immunoglobulin-like receptor and human leukocyte antigen genes and immunity to malaria
Stephen Tukwasibwe, Annettee Nakimuli, James A. Traherne, et al.
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 8, pp. 799-806
Open Access | Times Cited: 30
Hepatocytes and the art of killing Plasmodium softly
Camila Marques-da-Silva, Clyde Schmidt-Silva, Samarchith P. Kurup
Trends in Parasitology (2024) Vol. 40, Iss. 6, pp. 466-476
Closed Access | Times Cited: 3
Infectious Diseases of Poverty in Children
Caitlin E. Hansen, Elijah Paintsil
Pediatric Clinics of North America (2015) Vol. 63, Iss. 1, pp. 37-66
Open Access | Times Cited: 29
Progress in the Development of Subunit Vaccines against Malaria
Mariusz Skwarczyński, Saranya Chandrudu, Berta Rigau-Planella, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 373-373
Open Access | Times Cited: 25
Evaluating antidisease immunity to malaria and implications for vaccine design
Temitope W. Ademolue, Gordon A. Awandare
Immunology (2017) Vol. 153, Iss. 4, pp. 423-434
Open Access | Times Cited: 27
Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with sera from Plasmodium falciparum endemic areas of Africa
Saidou Balam, Kazutoyo Miura, Imen Ayadi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Cytolytic circumsporozoite-specific memory CD4+ T cell clones are expanded during Plasmodium falciparum infection
Raquel Furtado, Mahinder Paul, Jinghang Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top